biproxi, Inc.

Biproxi, Inc. is a technology company that provides a specialized platform to connect institutional investors, operators, and developers in the commercial real estate sector, facilitating efficient capital partnerships. Founded in 2018 in New York, US, biproxi, Inc. focuses on enhancing capital markets within the commercial real estate sector.

The company has raised USD 10. 00 mn in Seed funding, led by Greycroft Partners, and has secured a total of USD 10. 00 mn across two deals. The founders include David Morake, Edmund Hatton, Gordon Smith, and Umair Iqbal, with leadership from CEO Umair Iqbal.

The latest funding round occurred on September 17, 2019. Biproxi specializes in providing a comprehensive platform that connects institutional investors, operators, and developers in the commercial real estate (CRE) sector. The core offering is the Biproxi Capital Network, which aggregates over USD 2 trillion in capital from various stakeholders, facilitating efficient partnerships within the capital markets. This network includes services such as equity, debt, loan sales, and fundraises, tailored for asset classes including multifamily, retail, industrial, and emerging assets.

Biproxi serves a diverse clientele, all vetted for their track records, ensuring access to institutional-quality deals across the United States, Canada, the United Kingdom, and select European countries. Biproxi generates revenue through its subscription-based model, allowing sponsors and investors to access the network and its services. Clients typically establish partnerships for capital raises, co-investments, and direct transactions within the platform. By streamlining access to capital and facilitating deal flow, Biproxi enhances the capital-raising process, which is designed to cater to the unique needs of institutional investors and developers.

Pricing plans for access to the platform or transaction fees are structured around the tailored services offered, ensuring effective navigation of the commercial real estate landscape. Biproxi plans to leverage its recent Seed funding of USD 10. 00 mn, raised in September 2019, to enhance its platform capabilities and expand its service offerings. The company aims to develop new product features, although specific release dates were not detailed.

Geographic expansion is also on the horizon, with targeted growth in additional markets within Europe, aiming to establish a broader presence by 2024.